Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

30.24
Delayed Data
As of May 26
 -0.19 / -0.62%
Today’s Change
18.52
Today|||52-Week Range
69.45
+0.30%
Year-to-Date
5 Things You Need to Know About Zika Virus
May 26 / MotleyFool.com - Paid Partner Content
Why Intrexon and Dominion Resources Are Excited About Natural Gas-to-Fuels
May 24 / MotleyFool.com - Paid Partner Content
Adding to a Quintet of Longs
May 25 / TheStreet.com - Paid Partner Content
Ziopharm Subpar Cancer Therapies Can't Support Lofty Market Valuation
May 20 / TheStreet.com - Paid Partner Content
Intrexon (XON) Stock Pops As Congress Hears Zika Testimony
May 24 / Zacks.com - Paid Partner Content
Intrexon's Risky Revenue Machine
May 17 / MotleyFool.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close30.43
Today’s open30.63
Day’s range30.05 - 30.94
Volume760,333
Average volume (3 months)2,191,581
Market cap$3.6B
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-71.38%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book5.11

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+0.08+0.28%
JUNOJuno Therapeutics In...+1.24+3.08%
KITEKite Pharma Inc-0.20-0.42%
OPHTOphthotech Corp+0.14+0.28%
Data as of 05/26/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Randal J. Kirk
Chief Financial Officer
Rick L. Sterling
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers

Search for Jobs